Titre : Dyssomnies

Dyssomnies : Questions médicales fréquentes

Termes MeSH sélectionnés :

Brain Ischemia
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Dyssomnies : Questions médicales les plus fréquentes", "headline": "Dyssomnies : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Dyssomnies : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-28", "dateModified": "2025-04-24", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Dyssomnies" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Troubles de la veille et du sommeil", "url": "https://questionsmedicales.fr/mesh/D012893", "about": { "@type": "MedicalCondition", "name": "Troubles de la veille et du sommeil", "code": { "@type": "MedicalCode", "code": "D012893", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.870" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Privation de sommeil", "alternateName": "Sleep Deprivation", "url": "https://questionsmedicales.fr/mesh/D012892", "about": { "@type": "MedicalCondition", "name": "Privation de sommeil", "code": { "@type": "MedicalCode", "code": "D012892", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.870.400.099" } } }, { "@type": "MedicalWebPage", "name": "Troubles du rythme circadien du sommeil", "alternateName": "Sleep Disorders, Circadian Rhythm", "url": "https://questionsmedicales.fr/mesh/D020178", "about": { "@type": "MedicalCondition", "name": "Troubles du rythme circadien du sommeil", "code": { "@type": "MedicalCode", "code": "D020178", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.870.400.200" } } }, { "@type": "MedicalWebPage", "name": "Troubles du sommeil d'origine intrinsèque", "alternateName": "Sleep Disorders, Intrinsic", "url": "https://questionsmedicales.fr/mesh/D020919", "about": { "@type": "MedicalCondition", "name": "Troubles du sommeil d'origine intrinsèque", "code": { "@type": "MedicalCode", "code": "D020919", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.870.400.800" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Troubles du sommeil par somnolence excessive", "alternateName": "Disorders of Excessive Somnolence", "url": "https://questionsmedicales.fr/mesh/D006970", "about": { "@type": "MedicalCondition", "name": "Troubles du sommeil par somnolence excessive", "code": { "@type": "MedicalCode", "code": "D006970", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.870.400.800.200" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Hypersomnie idiopathique", "alternateName": "Idiopathic Hypersomnia", "url": "https://questionsmedicales.fr/mesh/D020177", "about": { "@type": "MedicalCondition", "name": "Hypersomnie idiopathique", "code": { "@type": "MedicalCode", "code": "D020177", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.870.400.800.200.400" } } }, { "@type": "MedicalWebPage", "name": "Syndrome de Kleine-Levin", "alternateName": "Kleine-Levin Syndrome", "url": "https://questionsmedicales.fr/mesh/D017593", "about": { "@type": "MedicalCondition", "name": "Syndrome de Kleine-Levin", "code": { "@type": "MedicalCode", "code": "D017593", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.870.400.800.200.500" } } }, { "@type": "MedicalWebPage", "name": "Narcolepsie", "alternateName": "Narcolepsy", "url": "https://questionsmedicales.fr/mesh/D009290", "about": { "@type": "MedicalCondition", "name": "Narcolepsie", "code": { "@type": "MedicalCode", "code": "D009290", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.870.400.800.200.750" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Cataplexie", "alternateName": "Cataplexy", "url": "https://questionsmedicales.fr/mesh/D002385", "about": { "@type": "MedicalCondition", "name": "Cataplexie", "code": { "@type": "MedicalCode", "code": "D002385", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.870.400.800.200.750.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Cataplexie", "alternateName": "Cataplexy", "url": "https://questionsmedicales.fr/mesh/D002385", "about": { "@type": "MedicalCondition", "name": "Cataplexie", "code": { "@type": "MedicalCode", "code": "D002385", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.870.400.800.200.750.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Hypersomnie idiopathique", "alternateName": "Idiopathic Hypersomnia", "url": "https://questionsmedicales.fr/mesh/D020177", "about": { "@type": "MedicalCondition", "name": "Hypersomnie idiopathique", "code": { "@type": "MedicalCode", "code": "D020177", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.870.400.800.200.400" } } }, { "@type": "MedicalWebPage", "name": "Syndrome de Kleine-Levin", "alternateName": "Kleine-Levin Syndrome", "url": "https://questionsmedicales.fr/mesh/D017593", "about": { "@type": "MedicalCondition", "name": "Syndrome de Kleine-Levin", "code": { "@type": "MedicalCode", "code": "D017593", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.870.400.800.200.500" } } }, { "@type": "MedicalWebPage", "name": "Narcolepsie", "alternateName": "Narcolepsy", "url": "https://questionsmedicales.fr/mesh/D009290", "about": { "@type": "MedicalCondition", "name": "Narcolepsie", "code": { "@type": "MedicalCode", "code": "D009290", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.870.400.800.200.750" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Cataplexie", "alternateName": "Cataplexy", "url": "https://questionsmedicales.fr/mesh/D002385", "about": { "@type": "MedicalCondition", "name": "Cataplexie", "code": { "@type": "MedicalCode", "code": "D002385", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.870.400.800.200.750.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Cataplexie", "alternateName": "Cataplexy", "url": "https://questionsmedicales.fr/mesh/D002385", "about": { "@type": "MedicalCondition", "name": "Cataplexie", "code": { "@type": "MedicalCode", "code": "D002385", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.870.400.800.200.750.500" } } }, { "@type": "MedicalWebPage", "name": "Troubles de l'endormissement et du maintien du sommeil", "alternateName": "Sleep Initiation and Maintenance Disorders", "url": "https://questionsmedicales.fr/mesh/D007319", "about": { "@type": "MedicalCondition", "name": "Troubles de l'endormissement et du maintien du sommeil", "code": { "@type": "MedicalCode", "code": "D007319", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.870.400.800.800" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Dyssomnies", "alternateName": "Dyssomnias", "code": { "@type": "MedicalCode", "code": "D020920", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Omar Laraqui", "url": "https://questionsmedicales.fr/author/Omar%20Laraqui", "affiliation": { "@type": "Organization", "name": "Laboratoire de psychologie, Cognition, Santé, Socialisation, Reims, France." } }, { "@type": "Person", "name": "Christine Roland-Levy", "url": "https://questionsmedicales.fr/author/Christine%20Roland-Levy", "affiliation": { "@type": "Organization", "name": "Laboratoire de psychologie, Cognition, Santé, Socialisation, Reims, France." } }, { "@type": "Person", "name": "Nadia Manar", "url": "https://questionsmedicales.fr/author/Nadia%20Manar", "affiliation": { "@type": "Organization", "name": "Graduate School of Health Engineering, Casablanca, Morocco." } }, { "@type": "Person", "name": "Salwa Laraqui", "url": "https://questionsmedicales.fr/author/Salwa%20Laraqui", "affiliation": { "@type": "Organization", "name": "Graduate School of Health Engineering, Casablanca, Morocco." } }, { "@type": "Person", "name": "Tarik Ghailan", "url": "https://questionsmedicales.fr/author/Tarik%20Ghailan", "affiliation": { "@type": "Organization", "name": "Moroccan Society of Maritime Health, Tangier, Morocco." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Generative adversarial network-created brain SPECTs of cerebral ischemia are indistinguishable to scans from real patients.", "datePublished": "2022-11-05", "url": "https://questionsmedicales.fr/article/36335166", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-022-23325-3" } }, { "@type": "ScholarlyArticle", "name": "Neural cortical organoids from self-assembling human iPSC as a model to investigate neurotoxicity in brain ischemia.", "datePublished": "2023-01-18", "url": "https://questionsmedicales.fr/article/36655331", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/0271678X231152023" } }, { "@type": "ScholarlyArticle", "name": "Pulsed Electromagnetic Fields Protect Against Brain Ischemia by Modulating the Astrocytic Cholinergic Anti-inflammatory Pathway.", "datePublished": "2022-07-13", "url": "https://questionsmedicales.fr/article/35831547", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10571-022-01251-2" } }, { "@type": "ScholarlyArticle", "name": "LAMP-2A ablation in hippocampal CA1 astrocytes confers cerebroprotection and ameliorates neuronal injury after global brain ischemia.", "datePublished": "2022-09-04", "url": "https://questionsmedicales.fr/article/36059143", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/bpa.13114" } }, { "@type": "ScholarlyArticle", "name": "Activated neutrophil-derived exosomes contribute to blood-brain barrier damage and hemorrhagic transformation after cerebral ischemia/reperfusion.", "datePublished": "2023-04-26", "url": "https://questionsmedicales.fr/article/37116559", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.brainres.2023.148374" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Troubles mentaux", "item": "https://questionsmedicales.fr/mesh/D001523" }, { "@type": "ListItem", "position": 3, "name": "Troubles de la veille et du sommeil", "item": "https://questionsmedicales.fr/mesh/D012893" }, { "@type": "ListItem", "position": 4, "name": "Dyssomnies", "item": "https://questionsmedicales.fr/mesh/D020920" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Dyssomnies - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Dyssomnies", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-11", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Dyssomnies", "description": "Comment diagnostique-t-on une dyssomnie ?\nQuels tests sont utilisés pour évaluer le sommeil ?\nQuels critères sont utilisés pour le diagnostic ?\nLes dyssomnies sont-elles liées à d'autres troubles ?\nQui peut diagnostiquer une dyssomnie ?", "url": "https://questionsmedicales.fr/mesh/D020920?mesh_terms=Brain+Ischemia&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Dyssomnies", "description": "Quels sont les symptômes courants des dyssomnies ?\nComment l'insomnie se manifeste-t-elle ?\nQu'est-ce que l'hypersomnie ?\nLes dyssomnies affectent-elles l'humeur ?\nQuels signes indiquent une fatigue diurne ?", "url": "https://questionsmedicales.fr/mesh/D020920?mesh_terms=Brain+Ischemia&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Dyssomnies", "description": "Comment prévenir les dyssomnies ?\nL'exercice aide-t-il à prévenir les troubles du sommeil ?\nQuels aliments éviter avant de dormir ?\nLe stress influence-t-il le sommeil ?\nLes siestes sont-elles bénéfiques ?", "url": "https://questionsmedicales.fr/mesh/D020920?mesh_terms=Brain+Ischemia&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Dyssomnies", "description": "Quels traitements sont disponibles pour les dyssomnies ?\nComment la thérapie cognitivo-comportementale aide-t-elle ?\nQuels médicaments sont utilisés pour traiter l'insomnie ?\nL'hygiène du sommeil est-elle efficace ?\nLes traitements sont-ils personnalisés ?", "url": "https://questionsmedicales.fr/mesh/D020920?mesh_terms=Brain+Ischemia&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Dyssomnies", "description": "Quelles sont les complications des dyssomnies ?\nLes dyssomnies peuvent-elles affecter la performance au travail ?\nY a-t-il un lien entre dyssomnies et obésité ?\nLes dyssomnies augmentent-elles le risque de dépression ?\nComment les dyssomnies affectent-elles la santé physique ?", "url": "https://questionsmedicales.fr/mesh/D020920?mesh_terms=Brain+Ischemia&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Dyssomnies", "description": "Quels sont les facteurs de risque des dyssomnies ?\nL'âge influence-t-il les dyssomnies ?\nLes médicaments peuvent-ils causer des dyssomnies ?\nLe mode de vie influence-t-il le sommeil ?\nLes troubles de santé augmentent-ils le risque ?", "url": "https://questionsmedicales.fr/mesh/D020920?mesh_terms=Brain+Ischemia&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on une dyssomnie ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'historique du sommeil, des questionnaires et parfois des études du sommeil." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer le sommeil ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "La polysomnographie et les journaux de sommeil sont couramment utilisés pour évaluer les troubles du sommeil." } }, { "@type": "Question", "name": "Quels critères sont utilisés pour le diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les critères incluent la durée du sommeil, la qualité et l'impact sur la vie quotidienne." } }, { "@type": "Question", "name": "Les dyssomnies sont-elles liées à d'autres troubles ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent être associées à des troubles psychiatriques ou médicaux comme l'anxiété." } }, { "@type": "Question", "name": "Qui peut diagnostiquer une dyssomnie ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Un médecin généraliste ou un spécialiste du sommeil peut poser le diagnostic." } }, { "@type": "Question", "name": "Quels sont les symptômes courants des dyssomnies ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent l'insomnie, l'hypersomnie, la fatigue diurne et des troubles de concentration." } }, { "@type": "Question", "name": "Comment l'insomnie se manifeste-t-elle ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "L'insomnie se manifeste par des difficultés à s'endormir, des réveils fréquents ou un sommeil non réparateur." } }, { "@type": "Question", "name": "Qu'est-ce que l'hypersomnie ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "L'hypersomnie est un besoin excessif de sommeil, même après une nuit de sommeil prolongée." } }, { "@type": "Question", "name": "Les dyssomnies affectent-elles l'humeur ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent entraîner des changements d'humeur, de l'irritabilité et de l'anxiété." } }, { "@type": "Question", "name": "Quels signes indiquent une fatigue diurne ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "La fatigue diurne se manifeste par une somnolence excessive, des difficultés de concentration et une baisse de performance." } }, { "@type": "Question", "name": "Comment prévenir les dyssomnies ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir une routine de sommeil régulière, éviter les stimulants et créer un environnement propice au sommeil." } }, { "@type": "Question", "name": "L'exercice aide-t-il à prévenir les troubles du sommeil ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier peut améliorer la qualité du sommeil et réduire le stress." } }, { "@type": "Question", "name": "Quels aliments éviter avant de dormir ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Évitez la caféine, l'alcool et les repas lourds avant de dormir pour favoriser un meilleur sommeil." } }, { "@type": "Question", "name": "Le stress influence-t-il le sommeil ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress peut aggraver les dyssomnies, rendant la gestion du stress essentielle." } }, { "@type": "Question", "name": "Les siestes sont-elles bénéfiques ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Des siestes courtes peuvent être bénéfiques, mais des siestes longues peuvent perturber le sommeil nocturne." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour les dyssomnies ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la thérapie cognitivo-comportementale, les médicaments et l'hygiène du sommeil." } }, { "@type": "Question", "name": "Comment la thérapie cognitivo-comportementale aide-t-elle ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Elle aide à modifier les pensées et comportements liés au sommeil, améliorant ainsi la qualité du sommeil." } }, { "@type": "Question", "name": "Quels médicaments sont utilisés pour traiter l'insomnie ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les benzodiazépines et les non-benzodiazépines sont souvent prescrites pour traiter l'insomnie." } }, { "@type": "Question", "name": "L'hygiène du sommeil est-elle efficace ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des habitudes de sommeil saines peuvent améliorer la qualité du sommeil et réduire les symptômes." } }, { "@type": "Question", "name": "Les traitements sont-ils personnalisés ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements sont souvent adaptés en fonction des besoins individuels et des causes sous-jacentes." } }, { "@type": "Question", "name": "Quelles sont les complications des dyssomnies ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des problèmes de santé mentale, des maladies cardiovasculaires et des troubles cognitifs." } }, { "@type": "Question", "name": "Les dyssomnies peuvent-elles affecter la performance au travail ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent entraîner une baisse de concentration, de productivité et des accidents au travail." } }, { "@type": "Question", "name": "Y a-t-il un lien entre dyssomnies et obésité ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les troubles du sommeil peuvent contribuer à l'obésité en perturbant les hormones de la faim." } }, { "@type": "Question", "name": "Les dyssomnies augmentent-elles le risque de dépression ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il existe un lien fort entre les troubles du sommeil et le développement de la dépression." } }, { "@type": "Question", "name": "Comment les dyssomnies affectent-elles la santé physique ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent augmenter le risque de maladies chroniques, d'hypertension et de diabète." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque des dyssomnies ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent le stress, les troubles psychiatriques, l'âge avancé et les habitudes de sommeil irrégulières." } }, { "@type": "Question", "name": "L'âge influence-t-il les dyssomnies ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées sont plus susceptibles de souffrir de dyssomnies en raison de changements physiologiques." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils causer des dyssomnies ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains médicaments, comme les antidépresseurs, peuvent perturber le sommeil." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il le sommeil ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire et une mauvaise hygiène de sommeil augmentent le risque de dyssomnies." } }, { "@type": "Question", "name": "Les troubles de santé augmentent-ils le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des conditions comme l'apnée du sommeil et l'anxiété augmentent le risque de dyssomnies." } } ] } ] }

Sources (10000 au total)

Pulsed Electromagnetic Fields Protect Against Brain Ischemia by Modulating the Astrocytic Cholinergic Anti-inflammatory Pathway.

Neuroinflammation is one of the most important pathological processes following brain ischemia. Pulsed electromagnetic fields (PEMFs) protect against brain ischemia, but their role in regulating neuro...

Activated neutrophil-derived exosomes contribute to blood-brain barrier damage and hemorrhagic transformation after cerebral ischemia/reperfusion.

Hemorrhagic transformation (HT) caused by blood-brain barrier (BBB) damage is closely correlated with the poor prognosis of ischemic stroke. Neutrophils are proven to mediate BBB injury after ischemic... A tMCAO-HT model was constructed to assess neutrophil infiltration and its co-localization with brain microvascular endothelial cells (BMEC). After using quiet (Q-Neu) and activated neutrophil (A-Neu)... Different degrees of cerebral hemorrhage were observed in the tMCAO-HT model. The expression of the neutrophil marker Ly6G was significantly increased in tMCAO-HT model compared to the sham group, and... Neutrophils are abnormally recruited in HT after ischemic stroke, and are associated with cerebral hemorrhage. In vitro, A-Neu-derived exosomes facilitate BBB injury, which may be accomplished by exos...

Brain-targeted heptapeptide-loaded exosomes attenuated ischemia-reperfusion injury by promoting the transfer of healthy mitochondria from astrocytes to neurons.

The exchange of mitochondria reportedly plays an important role in cell-cell communication in the central nervous system (CNS). The transfer of fragmented and dysfunctional astrocytic mitochondria int... In this study, we prepared macrophage-derived exosomes laden with heptapeptide (Hep) as a dynamin-related protein-1 (Drp1)-fission 1 (Fis1) peptide inhibitor P110 to alleviate cerebral ischemia-reperf... The results demonstrated that Hep-loaded macrophage-derived exosomes (EXO-Hep) reduced mitochondrial damage in astrocytes by inhibiting the Drp1/Fis1 interaction after ischemia-reperfusion, ensuring t... EXO-Hep significantly mitigated ischemic injury in a model of transient middle cerebral artery occlusion (tMCAO) by reducing the infarct area and improving neurological performance during the process ...

Whole-brain CT Perfusion at Admission and During Delayed Time-window Detects the Delayed Cerebral Ischemia in Patients with Aneurysmal Subarachnoid Hemorrhage.

To evaluate the utility of computed tomography perfusion (CTP) both at admission and during delayed cerebral ischemia time-window (DCITW) in the detection of delayed cerebral ischemia (DCI) and the ch... Eighty patients underwent CTP at admission and during DCITW. The mean and extreme values of all CTP parameters at admission and during DCITW were compared between the DCI group and non-DCI group, and ... With the exception of cerebral blood volume (P=0.295, admission; P=0.682, DCITW), there were significant differences in the mean quantitative CTP parameters between DCI and non-DCI patients both at ad... Whole-brain CTP can predict the occurrence of DCI at admission and diagnose DCI during DCITW. The extreme quantitative parameters and qualitative color-coded perfusion maps can better reflect the perf...

Leucine-Rich Alpha-2-Glycoprotein 1 is a Systemic Biomarker of Early Brain Injury and Delayed Cerebral Ischemia After Subarachnoid Hemorrhage.

After subarachnoid hemorrhage (SAH), early brain injury (EBI) and delayed cerebral ischemia (DCI) lead to poor outcomes. Discovery of biomarkers indicative of disease severity and predictive of DCI is... We performed untargeted proteomics using mass spectrometry in plasma samples collected at < 48 h of SAH in two independent discovery cohorts (n = 27 and n = 45) and identified LRG1 as a biomarker for ... Untargeted proteomics revealed higher plasma LRG1 levels across EBI severity and DCI in both discovery cohorts. In the validation cohort, the levels of LRG1 were higher in the DCI group compared with ... Plasma LRG1 is a biomarker for EBI, DCI, and functional outcomes after SAH. Further studies to elucidate the role of LRG1 in the pathophysiology of SAH are needed....

Higher Levels of Admission N-Terminal Pro-brain Natriuretic Peptide are Associated with Delayed Cerebral Ischemia Following Aneurysmal Subarachnoid Hemorrhage.

Delayed cerebral ischemia (DCI) greatly influences the prognosis of patients with aneurysmal subarachnoid hemorrhage (aSAH). We aimed to determine whether higher levels of admission N-terminal pro-bra... We retrospectively reviewed consecutive patients with aSAH between January 2018 and April 2021 in our department. Patients with admission NT-pro BNP were included for analysis. The associations betwee... A total of 415 patients with aSAH were included, among whom DCI occurred in 53 (12.8%). The admission NT-pro BNP levels were positively correlated with the cardiac troponin T levels and were significa... Higher admission levels of NT-pro BNP correlated with neurogenic cardiac injury and predicted the occurrence of DCI in patients with aSAH. A combination of the modified Fisher scale and admission NT-p...